Chromis is developing an innovative pipeline of therapeutics to cure chronic HBV

Chromis is developing an innovative pipeline of therapeutics to cure chronic HBV

Chromis is developing an innovative pipeline of therapeutics to cure chronic HBV

Cure for
Chronic Hepatitis B

400 Million People Suffer from
Chronic HBV Infection

HBV is the leading cause of cancer-related morbidity and mortality worldwide

HBV is the leading cause of cancer-related morbidity and mortality worldwide

HBV is the leading cause of cancer-related
morbidity and mortality worldwide

400 Million People Suffer from
Chronic HBV Infection

About Chronic
HBV Infection

HBV is the leading cause of cancer-related morbidity and mortality worldwide

CHR101

By disrupting the HBV lifecycle, our lead drug candidate
has the potential to eradicate
chronic HBV infection

By disrupting the HBV lifecycle, our lead drug candidate has the potential to eradicate chronic HBV infection

By disrupting the HBV life cycle,
our lead drug candidate has the
potential to eradicate chronic HBV infection

CHR101

Slider

Compas

6605 Nancy Ridge Dr., San Diego, CA, 92121

 

Contact

 bottle

CHR101 has the potential to eradicate HBV and to cure chronically infected HBV patients

 

Technology 

 

Calendar

Learn more about our news and events in 2016

 

 Events